NOV 29, 2020 3:57 AM PST

Gene Therapy for Eye Disorder May Have Other Applications

WRITTEN BY: Carmen Leitch

In recent years, scientists have been able to develop gene therapies to treat some eye diseases. The eyes are uniquely qualified as good gene therapy candidates; they are very easy to access compared to most organs, and they don't mount much of an immune response against foreign substances like grafts or gene therapy vectors. Now researchers have created a gene therapy for an eye disease called dominant optic atrophy (DOA). The work has been reported in Frontiers in Neuroscience.

A fluorescent microscope image with mitochondria highlighted in gold. This healthy cell shows a highly elaborate and well-connected network of mitochondria. Credit  Professor Jane Farrar and Dr Daniel Maloney, Trinity College Dublin

DOA usually affects people in early adulthood and is characterized by optic nerve degeneration. It causes a progressive loss of vision, including color vision defects. The severity of vision loss can vary from one patient to another. Symptoms tend to get worse as time goes on and some patients may become blind. Right now, there are no treatments or preventive medications for DOA, which affects as many as one in 50,000 people worldwide.

DOA is caused by mutations in a gene called OPA1. The OPA1 protein is crucial for the function of mitochondria, cellular organelles that act as power generators. Mutations in OPA1 cause mitochondrial dysfunction, which leads to the symptoms of the disorder.

In this work, the researchers tested the gene therapy in a mouse model; it successfully maintained visual function by targeting the dysfunctional mitochondria and helping to restore them. The strategy also worked in a human cell culture model, which suggests that it could also help patients.

A fluorescent microscope image with mitochondria highlighted in gold. This cell completely lacks OPA1 protein and shows fragmented mitochondria. Credit  Professor Jane Farrar and Dr Daniel Maloney, Trinity College Dublin

"We used a clever lab technique that allows scientists to provide a specific gene to cells that need it using specially engineered non-harmful viruses. This allowed us to directly alter the functioning of the mitochondria in the cells we treated, boosting their ability to produce energy which in turn helps protects them from cell damage," explained study co-leader Dr. Daniel Maloney, Research Fellow at Trinity College Dublin.

"Excitingly, our results demonstrate that this OPA1-based gene therapy can potentially provide benefit for diseases like DOA, which are due to OPA1 mutations, and also possibly for a wider array of diseases involving mitochondrial dysfunction."

Because mitochondrial dysfunction has also been implicated in a range of other diseases, including Alzheimer's and Parkinson's, this work could aid in the development of treatments for other disorders.

"We are very excited by the prospect of this new gene therapy strategy, although it is important to highlight that there is still a long journey to complete from a research and development perspective before this therapeutic approach may one day be available as a treatment," noted study co-leader Professor Jane Farrar, a Research Professor at Trinity's School of Genetics and Microbiology. She is featured in the video.

"OPA1 mutations are involved in DOA and so this OPA1-based therapeutic approach is relevant to DOA. However mitochondrial dysfunction is implicated in many neurological disorders that collectively affect millions of people worldwide. We think there is great potential for this type of therapeutic strategy targeting mitochondrial dysfunction to provide benefit and thereby make a major societal impact. Having worked together with patients over many years who live with visual and neurological disorders it would be a privilege to play a role in a treatment that may one day help many."

Sources: AAAS/Eurekalert! via Trinity College Dublin, Frontiers in Neuroscience

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
MAY 04, 2021
Genetics & Genomics
The Weird World of Flatfish
MAY 04, 2021
The Weird World of Flatfish
Many of us have wondered how fish like sole and flounder ended up with two eyes on one side of their heads, including sc ...
MAY 25, 2021
Cell & Molecular Biology
A simplified high-throughput protein expression system
MAY 25, 2021
A simplified high-throughput protein expression system
Protein synthesis, protein engineering, and synthetic biology researchers can research their protein of interest using e ...
JUN 08, 2021
Genetics & Genomics
Primers and Probes to Assay for SARS-CoV-2 Variants in Research Samples
JUN 08, 2021
Primers and Probes to Assay for SARS-CoV-2 Variants in Research Samples
Today, many scientists are investigating SARS-CoV-2 variants in their research projects. In order to facilitate screenin ...
JUN 17, 2021
Genetics & Genomics
Fish Adapted to Toxins Pass Epigenetic Changes Onto Offspring
JUN 17, 2021
Fish Adapted to Toxins Pass Epigenetic Changes Onto Offspring
Parents pass down their genes to their offspring, and it seems that epigenetic features, which can affect gene activity ...
JUL 18, 2021
Genetics & Genomics
Researchers Find Strange 'Borg' DNA - It's Assimilating
JUL 18, 2021
Researchers Find Strange 'Borg' DNA - It's Assimilating
Our environment is full of DNA molecules. While researchers have become concerned about DNA waste material that's ac ...
JUL 21, 2021
Genetics & Genomics
Researchers Detect DNA in Air Samples
JUL 21, 2021
Researchers Detect DNA in Air Samples
Scientists have shown that it's possible to assess what organisms might be living in a particular habitat by collecting ...
Loading Comments...